Renaissance Technologies - ACHILLES THERAPEUTICS PLC ownership

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ACHILLES THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$398
-6.4%
437,528
-2.7%
0.00%0.0%
Q2 2023$425
+16.8%
449,733
+18.3%
0.00%
Q1 2023$364
-16.5%
380,233
-21.6%
0.00%
-100.0%
Q4 2022$436
-99.8%
484,733
+498.2%
0.00%
Q3 2022$183,000
-16.8%
81,033
-7.1%
0.00%
Q2 2022$220,000
+144.4%
87,233
+185.7%
0.00%
Q1 2022$90,000
-29.7%
30,533
+19.6%
0.00%
Q4 2021$128,00025,5330.00%
Other shareholders
ACHILLES THERAPEUTICS PLC shareholders Q4 2023
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 11,086,909$9,978,21815.84%
Artal Group S.A. 2,255,375$2,0300.11%
Redmile Group, LLC 1,608,089$1,447,2800.06%
RA Capital Management 1,607,834$1,447,0510.03%
Forefront Analytics, LLC 30,525$27,4730.02%
Baker Brothers Advisors 2,591,366$2,332,2290.01%
Point72 Asset Management, L.P. 1,413,809$1,272,4280.00%
Virtu Financial LLC 31,003$280.00%
Ergoteles LLC 22,004$19,8040.00%
CANTOR FITZGERALD, L. P. 40,000$360.00%
View complete list of ACHILLES THERAPEUTICS PLC shareholders